Traditional Dietary Advice Versus Reassurance-alone in Postprandial Functional Dyspepsia
Randomised Trial of Traditional Dietary Advice Versus Reassurance-alone in Postprandial Functional Dyspepsia
Sheffield Teaching Hospitals NHS Foundation Trust
50 participants
Sep 1, 2022
INTERVENTIONAL
Conditions
Summary
Functional dyspepsia is common, affecting 7.2% of the global population, and associated with substantial health impairment. Almost 80% of patients with functional dyspepsia report meal-related symptoms and are classified as having the postprandial distress syndrome (PDS) variant. However, studies evaluating dietary modifications in PDS are sparse. The investigators will perform a single-centre randomised trial evaluating traditional dietary advice (TDA) in PDS. 50 patients with PDS will be randomly assigned to a leaflet explaining reassurance-alone +/- TDA. The reassurance-alone group will be informed of the absence of organic disease and provided a diagnostic explanation of functional dyspepsia. The TDA group will receive the same information but also be recommended to eat smaller, regular meals and reduce the intake of caffeine/alcohol/fizzy drinks, fatty/processed/spicy foods, and fibre. Questionnaires are to be completed during the 4-week trial, including self-reported adequate relief of dyspeptic symptoms, and the validated Leuven Postprandial Distress Scale (LPDS), Gastrointestinal Symptom Rating Scale, and Napean Dyspepsia Quality of Life Index. The primary endpoint(s) to define clinical response will be evaluated over weeks 3-4 as, i) ≥50% adequate relief of dyspeptic symptoms, and ii) \>0.5-point reduction in the PDS subscale of the LPDS (calculated as the mean scores for early satiety, postprandial fullness, and upper abdominal bloating).
Eligibility
Inclusion Criteria4
- Fulfil Rome IV symptoms criteria for functional dyspepsia
- Normal upper gastrointestinal endoscopy within last 3 years
- Online access
- English literate
Exclusion Criteria12
- Organic gastrointestinal diseases (e.g. inflammatory bowel disease, GI cancer, coeliac disease)
- Major abdominal surgery (except laparoscopy, appendectomy, cholecystectomy)
- Documented H.pylori in the last 3 months
- History of eating disorders
- Body mass index <20
- Current use of opioids or anti-inflammatory drugs
- Severe systemic disease (e.g. cardiac, renal, respiratory) necessitating frequent medical consultations
- Pregnant
- Diabetes mellitus
- Scleroderma
- Memory impairment
- Current dietary interventions
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
To be informed of the absence of organic disease and provided a diagnostic explanation of functional dyspepsia
To receive the same information as reassurance-alone group but also recommended to eat smaller, regular meals and reduce the intake of caffeine/alcohol/fizzy drinks, fatty/processed/spicy foods, and fibre
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05718960